Date | Analyst | Company | Last | Target | Call | Valuation |
01/07/22 | CIMB | Hyphens Pharma | 0.295 | 0.36 | Add | DCF, PER13.5x FY22 |
04/04/22 | Amfrasers | Hyphens Pharma | 0.29 | 0.38 | Outperform | PER15x FY22 |
04/07/22 | SAC Capital | Hyphens Pharma | 0.3 | 0.4 | Buy | |
05/13/22 | Lim & Tan | Hyphens Pharma | 0.28 | 0.37 | Buy | |
05/20/22 | CIMB | Hyphens Pharma | 0.28 | 0.36 | Add | |
05/20/22 | SAC Capital | Hyphens Pharma | 0.28 | 0.4 | Buy | |
06/06/22 | Phillip | Hyphens Pharma | 0.295 | 0.43 | Buy | DCF |
08/18/22 | CIMB | Hyphens Pharma | 0.315 | 0.39 | Add | DCF |
08/29/22 | Phillip | Hyphens Pharma | 0.31 | 0.43 | Buy | DCF |
11/25/22 | CIMB | Hyphens Pharma | 0.3 | 0.4 | Add | DCF |
03/09/23 | Phillip | Hyphens Pharma | 0.35 | 0.445 | Buy | DCF |
04/13/23 | CIMB | Hyphens Pharma | 0.34 | 0.4 | Add | DCF |
Saturday, April 15, 2023
Hyphens Pharma - Stock calls
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment